GlassScriptPhysician profile
Joseph Rutledge
NPI 1750709523
$95,658.44
in general payments reported to CMS, 2019-2025
47 companies · $28K in 2025
The $28K reported for 2025 was more than what 97% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,807 · 2020: $2,261 · 2021: $4,165 · 2022: $9,428 · 2023: $17K · 2024: $32K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $15K · Travel and Lodging: $14K · Food and Beverage: $9,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,732.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $15,032.50 |
| Travel and Lodging | $13,935.05 |
| Food and Beverage | $9,297.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $49,386.19 | 2019-2025 | Sprint Pns System |
| Biotronik Nro, INC. | $20,727.64 | 2024-2025 | Prospera |
| Boston Scientific Corporation | $6,249.21 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Tersera Therapeutics LLC | $6,124.16 | 2020-2025 | Prialt |
| Abbott Laboratories | $5,713.95 | 2019-2025 | Proclaim |
| Abbvie INC. | $1,762.27 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Vertos Medical, INC. | $1,399.34 | 2020-2024 | Mild Device Kit |
| Merz North America, INC. | $598.24 | 2023 | Xeomin |
| Medtronic, INC. | $508.62 | 2021-2024 | Vanta Adaptivestim, Synchromedii, Kyphon Express II Kyphopak Tray |
| Painteq LLC | $312.34 | 2023-2024 | Painteq |
| Amgen INC. | $244.81 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $243.96 | 2021-2022 | |
| Stryker Corporation | $186.01 | 2024 | Mild Device Kit |
| Medtronic USA, INC. | $184.55 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $155.04 | 2020-2021 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rutledge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.